Dynamically Tailored Behavioral Interventions in Diabetes
Part of paid clinical trials in New York, New York.
- Sponsor
- Columbia University
- Study ID
- NCT04226027
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- T2.coach — BEHAVIORALT2.coach is a smartphone app for low-burden capture of diet and blood glucose (BG) levels and for reviewing past records, integrated with FitBit for captured of physical activity and sleep. All captured data are sent to the computational inference engine that uses machine learning methods and expert system to formulate personalized behavioral goals. Examples of behavioral goals include the following: "For high carbohydrate breakfasts, reduce your carbs to be about 1 carb choice. Examples of 1 carb choice are 1 slice of whole wheat toast, 1 cup of oatmeal, or 1 apple." The T2.coach chatbot companion uses text messages to help individuals set goals that are consistent with evidence based guidelines for diabetes self-management, inferences on data captured with T2.coach, and their own preferences, as well as send individuals goal reminders and prompts for reflection on goal achievement.
Study Details
In this project, the investigators will evaluate the efficacy of a novel approach to personalizing behavioral interventions for self-management of type 2 diabetes (T2DM) to individuals' behavioral and glycemic profiles discovered using computational learning and self-monitoring data. This study is a two-arm randomized controlled trial with n=280 participants recruited from the participating Federally Qualified Health Centers (FQHCs). The participants will be randomly assigned to the intervention group and the usual care (control) group with 1-1 allocation ratio. Half of the participants (n=140) will be randomly assigned to a usual care (control) group. Both groups will receive standard diabetes education at their respective FQHC site. In addition, the experimental group will receive instructions to use T2.coach for a minimum of 6 months.
Key Dates
- First listed
- Jan 13, 2020
- Start date
- Jan 17, 2020
- Status verified
- Apr 2026
- Primary completion
- Mar 30, 2025
- Completion
- Mar 30, 2025
Study Design
- Enrollment
- 300 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: T2.coachParticipants receive standard care (diabetes self-management education provided by their Federally Qualified Community Health Center) and are asked to use T2.coach for 6 months.
- No Intervention: ControlParticipants receive standard care (diabetes self-management education provided by their Federally Qualified Community Health Center).
Primary Outcome Measure
Mean HbA1c Value [ Time Frame: Baseline, 6 months, 12 months ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Clinical Directors Network | New York | New York | 10018 | - |
| Columbia University Irving Medical Center | New York | New York | 10032 | - |
Find similar trials in New York, NY
Related Studies
- Implementing an Effective Diabetes Intervention Among Low-Income ImmigrantsRecruiting · NYU Langone Health · New York, New York
- LINK-IT: Leveraging vIdeos and commuNity Health worKers to Improve Diabetes OuTcomesRecruiting · NYU Langone Health · New York, New York
- High Fructose Diet, the Gut Microbiome, and Metabolic HealthRecruiting · Icahn School of Medicine at Mount Sinai · New York, New York
- A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)PHASE3 · Recruiting · Eli Lilly and Company · Tucson, Arizona